Now comes Kirton and his advisory council’s most ambitious project, the virtual ALS Super Auction, between Feb. 6-20. Every ...

Despite the discontinuations, CEO Pascal Soriot said AstraZeneca’s December 2020 acquisition of Alexion was a “fantastic” ...

Repeated brain injury resulted in SOD1-ALS mice showing greater weight loss, an earlier tremor in the hind limbs, and ...

Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today announced it will participate in a fireside chat at the Oppenheimer 25 th Annual ...

Qure is planning soon to start enrolling patients in a second dose group as part of a clinical trial testing AMT-162 for SOD1 ...

The Valentine Plunge has raised nearly $5 million for the Joan Dancy and P.A.L.S. (People with ALS) Foundation.

Neurizon Therapeutics has achieved a key milestone with a patent granted in the US for its lead drug candidate NUZ-001 to ...

Second Clinical Trial Getting Underway for PathMaker's Non-Invasive ALS Treatment Platform. BOSTON, Feb. 04, 2025 (GLOBE NEWSWIRE) -- PathMaker Neurosystems Inc. ("PathMaker”), ...

Medicare is a government-sponsored health program for people 65 and older, as well as those with certain disabilities, ...

Roy Woodlief, center, poses with Wake County Sheriff Donnie Harrison and Terry Putnam after Woodlief graduated the academy ...